(Q42730725)

5 November 2017

title

Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer (English)

1 reference

5 November 2017

Seok-Jun Kim

1

1 reference

5 November 2017

Ji-Young Shin

2

1 reference

5 November 2017

Teak-Chin Cheong

3

1 reference

5 November 2017

Il-Ju Choi

4

1 reference

5 November 2017

Yeon Su Lee

5

1 reference

5 November 2017

Seok Hee Park

6

1 reference

5 November 2017

Kyung-Hee Chun

7

1 reference

5 November 2017

publication date

13 July 2011

1 reference

Clinical & Experimental Metastasis

5 November 2017

published in

1 reference

5 November 2017

volume

28

1 reference

5 November 2017

issue

8

1 reference

5 November 2017

page(s)

743-750

1 reference

Galectins as modulators of tumour progression

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectins as modulators of cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Increased expression of the LGALS3 (Galectin 3) gene in human non–small‐cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3, a novel binding partner of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Colorectal cancer and genetic alterations in the Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Wnt activation and alternative promoter repression of LEF1 in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9406-8

Galectin-3 and metastasis

21 January 2018

1 reference

12 December 2020

Wnt pathway is involved in advanced gastric carcinoma

1 reference

12 December 2020

Quantitative Proteomic and Genomic Profiling Reveals Metastasis-Related Protein Expression Patterns in Gastric Cancer Cells

1 reference

12 December 2020

Galectin-3 expression in colorectal cancer: relation to invasion and metastasis

1 reference

12 December 2020

The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling

1 reference

12 December 2020

Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes

1 reference

12 December 2020

beta-catenin gene mutation in invasive ductal breast cancer

1 reference

12 December 2020

Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma

1 reference

12 December 2020

Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line.

1 reference

12 December 2020

Galectin-3 and cancer (Review).

1 reference

12 December 2020

Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression

1 reference

12 December 2020

10.1007/S10585-011-9406-8

Identifiers

DOI

1 reference

Dimensions Publication ID

5 November 2017

1001878873

0 references

1 reference